MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with R

Roxadustat

Roxadustat 20mg tablets

No stability information

Stability notes for Roxadustat 20mg tablets

There are no stability notes for this medicine.

Supplier

Evrenzo 20mg tablets (Astellas Pharma Ltd)

Roxadustat 50mg tablets

No stability information

Stability notes for Roxadustat 50mg tablets

There are no stability notes for this medicine.

Supplier

Evrenzo 50mg tablets (Astellas Pharma Ltd)

Roxadustat 70mg tablets

No stability information

Stability notes for Roxadustat 70mg tablets

There are no stability notes for this medicine.

Supplier

Evrenzo 70mg tablets (Astellas Pharma Ltd)

Roxadustat 100mg tablets

No stability information

Stability notes for Roxadustat 100mg tablets

There are no stability notes for this medicine.

Supplier

Evrenzo 100mg tablets (Astellas Pharma Ltd)

Roxadustat 150mg tablets

No stability information

Stability notes for Roxadustat 150mg tablets

There are no stability notes for this medicine.

Supplier

Evrenzo 150mg tablets (Astellas Pharma Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.